Summary of CombiGene’s participation at BIO Europe in Stockholm, 4-6 November 2024
BIO Europe in Stockholm was characterized by openness and collaboration. The meeting is of great importance
BIO Europe in Stockholm was characterized by openness and collaboration. The meeting is of great importance
CombiGene and KTH have jointly received a grant from Vinnova of SEK 1 million to investigate
On September 18-19, CEO Peter Ekolind presented CombiGene at the Nordic Life Science Days (NLSDays) in
Annika Ericsson assumed the position of Chief Scientific Officer at CombiGene at the beginning of August
At the beginning of June, Jan Nilsson, former CEO and now Senior Advisor at CombiGene, together
The congress is arranged biannually and gathers clinicians and researchers from all over the world to
CombiGene’s Senior Program Director Alvar Grönberg recently visited 4th Gene Therapy for Neurological Disorders Europe in
CombiGene’s Chief Scientific Officer Karin Agerman and Senior Director In-licensing Birgitta Ståhl recently visited the ASGCT
Last week, the “46th Adipose Tissue Discussion Group” conference was held in Edinburgh, the capital of
One of the most exciting projects that CombiGene is involved in, and which is led by